HIV Required Training

Slide 1: HIV/Hepatitis B Puyallup School District

Slide 2: WE’RE YEAH, YEAH, WE’VE HEARD IT GONNA A HUNDRED TIMES! BUT LIVE WE KNOW ALL WE ALSO FOREVER! ABOUT AIDS! KNOW SOMETHING ELSE...

Slide 3: Reported Cases of AIDS in the United States 900000 800000 700000 600000 500000 400000 300000 200000 100000 0 81 83 85 87 89 91 94 96 98 00

Slide 4: Reported Cases of AIDS in Washington State 12000 10000 8000 6000 4000 2000 0 <82 84 86 88 90 92 94 96 98 00

Slide 5: AIDS: The Global Epidemic E a s t A s ia & P a c if ic 640,000 The World Health Organization says more than 40 million E a s te rn E uro p e /C entra l A s ia 700,000 people have been infected with A us tra lia /Oc e a nia 15,000 the AIDS virus since 1981. Lowest estimate by region: No rth A f ric a /M id d le E a s t 400,000 S o uth/S o uthe a s t A s ia 5.8 MILLION Wes tern E uro p e 540,000 La tin A meric a /C a rib b ea n 1.8 MILLION No rth A meric a 1,000,000 S ub -S a ha ra n A f ric a 26 MILLION 0 5 , 0 0 0 ,0 0 0 1 0,00 0,000 1 5,00 0,000 20,0 00,00 0 25,0 00,00 0

Slide 6: STAGES OF HIV INFECTION Symptomatic HIV Positive AIDS HIV Positive { Serious, debilitating symptoms leading to death Asymptomatic HIV-Positive Infected with the virus but have no symptoms (and often not aware they are HIV positive)

Slide 7: STAGES OF HIV INFECTION STAGE 1 STAGE 2 Acute infection and   Asymptomatic infection seroconversion  2 to 12 years after exposure 3 weeks to 3 months  to HIV after exposure to HIV STAGE 3  Pulmonary TB  Invasive Cervical Cancer  Neurological disease  Secondary Infectious Diseases  Secondary Cancer  CD4T Cell Count less than 200  Time After Exposure Unknown

Slide 8: How HIV Destroys The Immune System Step 1: HIV Step 4: HIV Multiplies l eria Step 3: Genetic Material Mat etic Gen HIV invades (Enters) Helper T-Cell “Atta cks” Step 2: Step 5: HIV Attached to HIV Breaks Away Helper T-Cell

Slide 9: “HIV TRANSMITTED IN BODY FLUIDS” How is the Virus Transmitted? by exchanging  Blood  Semen  Vaginal Secretions with a person who is infected with HIV

Slide 10: HEPATITIS Viral infection of the liver causes intestinal “flu-like” symptoms and jaundice (in adults). Hepatitis is caused by more than one type of virus but the most common types are Hepatitis A and Hepatitis B.

Slide 11: The Five Forms of Viral Hepatitis Hepatitis A (HAV)  Hepatitis B (HBV)  Hepatitis C (HCV;Non-A, Non-B)  Hepatitis D (HDV;Delta hepatitis)  Hepatitis E (HEV;Non-A, Non-B) 

Slide 12: Hepatitis B HEPATITIS B VIRUS- SYMPTOMS-  damages the liver  Mild to severe to fatal  blood borne infection  Loss of appetite, fatigue, TRANSMISSION- nausea, vomiting, abdominal pain and  sexual contact jaundice  blood exposure to open wounds  blood exposure to mucous membranes PROGRESSION-  acute hepatitis - 25%  carriers - 6-10% of acutely infected adults, 90% of newborns infected with HBV may develop chronic liver disease, cirrhosis, liver cancer, and 25% are infectious to others

Slide 13: How HEPATITIS A Differs From HEPATITIS B MODE OF TRANSMISSION HEPATITIS A HEPATITIS B BLOOD VERY RARE YES FECES YES NO SALIVA NO RARELY FOOD/WATER YES NO COURSE OF DISEASE 1-2 WEEKS OR MONTHS TO LENGTH OF ILLNESS RARELY, YEARS SEVERAL MONTHS RARE CHRONIC LIVER COMPLICATIONS DISEASE & CANCER CAN BE FATAL CARRIER STATE NO YES SYMPTOMS INTESTINAL FLU-LIKE ILLNESS YES YES NO YES LIVER DAMAGE YES, ADULTS YES

Slide 14: How are HIV and HBV Similar? Different? MODE OF TRANSMISSION HBV HIV BLOOD YES YES SEMEN YES YES VAGINAL FLUIDS YES YES SALIVA MAYBE NO TARGET IN THE BODY LIVER IMMUNE SYSTEM RISK OF INFECTION AFTER NEEDLESTICK 6-30% 0.5% EXPOSURE TO INFECTED BLOOD HIGH NUMBER OF VIRUSES IN BLOOD YES NO YES NO VACCINE AVAILABLE

Slide 15: Hepatitis B - Prevention Vaccine - Recommended for persons at  risk of exposure  Immune Globulin - Following exposure, temporary protection  Proper Use of Condoms, Lubricant and Spermicide (Not 100% Safe)  Don’t use Drugs or Share Needles Ever  Universal Precautions

Slide 16: “UNIVERSAL PRECAUTIONS” The term “universal precautions” refers to a method of infection control in which all human blood and other potentially infectious materials are treated as if known to be infectious for HIV and HBV. Universal precautions do not apply to feces, nasal secretions, sputum, sweat, tears, urine, or vomitus unless they contain visible blood.

Slide 17: Requirements for Confidentiality Regarding HIV/AIDS and Hepatitis B Students and Employees cannot be required to: x be tested x reveal their HIV/HBV status Sharing of information about a person’s HIV/HBV status may occur only following written permission. Strictly Confidential

Slide 18: Disclosure An employee who knows of another person’s HIV/HBV status may NOT share that information with anyone without the permission of that person or the parent of a person under 14 years of age. Violation of confidentiality by District employees is a misdemeanor and may place a person at risk of civil suit if such breach of confidentiality results in harm to the person who is HIV or HBV positive.

Slide 19: Discrimination EMPLOYEES Employers may not discriminate against an HIV/HBV infected person in: employment x leave x job assignment x recruitment x hiring x fringe benefits x transfers x layoffs x rate of pay x terminations x STUDENTS Students with HIV/HVB infection may not be discriminated against in: x placement x evaluation x activities x access to school equipment x course of study